Arch Biopartners Inc Total Liabilities

Latest as of March 2026: CA$4.11 Million CAD ≈ $2.97 Million USD

Arch Biopartners Inc total liabilities. Based on the latest financial reports, Arch Biopartners Inc (ARCH) has total liabilities worth CA$4.11 Million CAD (≈ $2.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Arch Biopartners Inc's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Arch Biopartners Inc (1997–2025)

Total liabilities of Arch Biopartners Inc from 1997 to 2025. This chart illustrates how Arch Biopartners Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Arch Biopartners Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Arch Biopartners Inc Competitors by Total Liabilities

The table below lists competitors of Arch Biopartners Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Omesti Bhd KLSE:9008	Malaysia	RM76.39 Million
Lion One Metals Limited V:LIO	Canada	CA$56.51 Million
Sportsmans NASDAQ:SPWH	USA	$704.35 Million
JP Morgan Global Growth & Income PLC LSE:JGGI	UK	GBX151.54 Million
Diginex Limited Ordinary Shares NASDAQ:DGNX	USA	$32.01 Million
ATA IMS Bhd KLSE:8176	Malaysia	RM178.02 Million
Ralco Agencies Ltd TA:RLCO	Israel	ILA71.02 Million
BrilliA Inc NYSE MKT:BRIA	USA	$15.92 Million

Liability Composition Analysis (1997–2025)

This chart breaks down Arch Biopartners Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Arch Biopartners Inc's balance sheet.

Liquidity & Leverage Metrics

Arch Biopartners Inc Total Liabilities Ratios Explained

Arch Biopartners Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	8.87	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arch Biopartners Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arch Biopartners Inc (1997–2025)

The table below shows the annual total liabilities of Arch Biopartners Inc from 1997 to 2025.

Year	Total Liabilities	Change
2025-09-30	CA$3.99 Million ≈ $2.88 Million	-24.55%
2024-09-30	CA$5.28 Million ≈ $3.82 Million	-20.92%
2023-09-30	CA$6.68 Million ≈ $4.83 Million	+31.20%
2022-09-30	CA$5.09 Million ≈ $3.68 Million	-22.26%
2021-09-30	CA$6.55 Million ≈ $4.74 Million	+42.12%
2020-09-30	CA$4.61 Million ≈ $3.33 Million	+32.85%
2019-09-30	CA$3.47 Million ≈ $2.51 Million	+101.91%
2018-09-30	CA$1.72 Million ≈ $1.24 Million	+172.19%
2017-09-30	CA$631.35K ≈ $456.71K	+30.46%
2016-09-30	CA$483.94K ≈ $350.08K	-4.74%
2015-09-30	CA$508.02K ≈ $367.50K	+23.19%
2014-09-30	CA$412.38K ≈ $298.31K	-10.78%
2013-09-30	CA$462.19K ≈ $334.34K	+2.89%
2012-09-30	CA$449.23K ≈ $324.97K	+13.15%
2011-09-30	CA$397.02K ≈ $287.20K	+7.18%
2010-09-30	CA$370.41K ≈ $267.95K	+6.58%
2009-09-30	CA$347.56K ≈ $251.42K	-86.49%
2008-09-30	CA$2.57 Million ≈ $1.86 Million	+30.33%
2007-09-30	CA$1.97 Million ≈ $1.43 Million	+23.52%
2006-09-30	CA$1.60 Million ≈ $1.16 Million	-21.86%
2005-09-30	CA$2.04 Million ≈ $1.48 Million	+1.47%
2004-09-30	CA$2.02 Million ≈ $1.46 Million	+28.74%
2003-09-30	CA$1.57 Million ≈ $1.13 Million	+3619.39%
2002-09-30	CA$42.08K ≈ $30.44K	-81.70%
2001-09-30	CA$229.99K ≈ $166.37K	-28.18%
2000-09-30	CA$320.21K ≈ $231.63K	+56.02%
1999-09-30	CA$205.23K ≈ $148.46K	-35.03%
1998-09-30	CA$315.90K ≈ $228.52K	-16.91%
1997-09-30	CA$380.18K ≈ $275.01K	--

About Arch Biopartners Inc

V:ARCH Canada Biotechnology

Market Cap

$40.79 Million

CA$56.38 Million CAD

Market Cap Rank

#22463 Global

#793 in Canada

Share Price

CA$0.83

Change (1 day)

+2.47%

52-Week Range

CA$0.41 - CA$1.45

All Time High

CA$5.00